Cadila Healthcare gets EIR from USFDA for its Ahmedabad facility
The company's topical manufacturing facility at Ahmedabad has received an EIR from the United States Food and Drug Administration (USFDA) signifying the successful closure of the audit, Cadila Healthcare said in a filing to the BSE. The facility completed the USFDA audit from December 16 to 20, 2019...